Author

Xiang Zhou

SiteOne Therapeutics (United States)ORCID 0000-0002-5727-6783Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xiang Zhou9 papers · McGill University

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:non-human primate· 1

Frequent Co-Authors

Anton Delwig· 1 shared Bryan D. MoyeriD· 1 shared David C. YeomansiD· 1 shared Dennis MonteleoneiD· 1 shared George Luu· 1 shared Hassan Pajouhesh· 1 shared Holly S. HajareiD· 1 shared J. Du BoisiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Anton Delwig

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Discovery of a Selective, State-Independent Inhibitor of NaV1.7 by Modification of Guanidinium Toxins

Hassan Pajouhesh, Jacob T. Beckley, Anton Delwig, Holly S. Hajare, George Luu, Dennis Monteleone, Xiang Zhou, Joseph Ligutti, Shanti M. Amagasu, Bryan D. Moyer, David C. Yeomans, J. Du Bois, John V. Mulcahy

This paper describes the discovery of ST-2262, a selective NaV1.7 inhibitor with state-independent action, showing reduced pain sensitivity in non-human primates.

Scientific Reports · Sep 9, 2020Peer-reviewedNeuroscience